Mulshine, James L. http://orcid.org/0000-0002-4648-9177
Avila, Riccardo S.
Sullivan, Daniel C.
Yankelevitz, David F.
San José Estépar, Raúl
Ambrose, Laurie Fenton
Pyenson, Bruce
Aldigé, Carolyn R.
Article History
Received: 27 August 2020
Accepted: 21 September 2020
First Online: 27 October 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: James L. Mulshine, M.D. – No conflicts with the contents of this submission.Rick Avila, MS – Mr. Rick Avila is a co-owner and CEO of Accumetra, LLC, a private company which develops and provides technology to improve the quality of CT imaging including calibration phantoms mentioned within this paper.Daniel C. Sullivan, M.D. – No conflicts with the contents of this submission.David F. Yankelevitz, M.D. – Dr. David Yankelevitz is a named inventor on a number of patents and patent applications related to the evaluation of diseases of the chest including measurement of nodules. Dr. Yankelevitz has received financial compensation for licensing of these patents. In addition, he is a consultant for and co-owner of Accumetra, a private company developing tools to improve the quality of CT imaging and is on the medical advisory board for Grail, a company that does blood tests for early detection of cancer.Raul San Jose Estepar, Ph.D. – Dr. Raul San Jose Estepar is co-founder and advisor of Quantitative Imaging Solutions, a private consulting company for imaging analytics and visualization.Laurie Fenton Ambrose – No conflicts with the contents of this submission.Bruce Pyenson, FSA, MAAA – No conflicts with the contents of this submission.Carolyn R. Aldigé – No conflicts with the contents of this submission.